| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6157543
[patent_doc_number] => 20020146712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Tumor suppressor'
[patent_app_type] => new
[patent_app_number] => 09/924654
[patent_app_country] => US
[patent_app_date] => 2001-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19431
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146712.pdf
[firstpage_image] =>[orig_patent_app_number] => 09924654
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/924654 | Tumor suppressor | Aug 6, 2001 | Abandoned |
| 09/763334 | Treatment and prevention of cancer and pituitary disorders with lats proteins, derivatives and fragments, and lats knock-out animal models | Aug 5, 2001 | Abandoned |
Array
(
[id] => 6544609
[patent_doc_number] => 20020137679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'COMP/TSP-1, COMP/TSP-2 and other TSP chimeric proteins'
[patent_app_type] => new
[patent_app_number] => 09/919603
[patent_app_country] => US
[patent_app_date] => 2001-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8018
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137679.pdf
[firstpage_image] =>[orig_patent_app_number] => 09919603
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/919603 | COMP/TSP-1, COMP/TSP-2 and other TSP chimeric proteins | Jul 29, 2001 | Abandoned |
Array
(
[id] => 6715796
[patent_doc_number] => 20030027144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Tumor antigen-derived gene 16 (TADG-16): a novel extracellular serine protease and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/907187
[patent_app_country] => US
[patent_app_date] => 2001-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12114
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027144.pdf
[firstpage_image] =>[orig_patent_app_number] => 09907187
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/907187 | Tumor antigen-derived gene 16 (TADG-16): a novel extracellular serine protease and uses thereof | Jul 16, 2001 | Abandoned |
Array
(
[id] => 1059758
[patent_doc_number] => 06852848
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 09/906646
[patent_app_country] => US
[patent_app_date] => 2001-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 124
[patent_figures_cnt] => 124
[patent_no_of_words] => 120230
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852848.pdf
[firstpage_image] =>[orig_patent_app_number] => 09906646
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/906646 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 15, 2001 | Issued |
Array
(
[id] => 6674226
[patent_doc_number] => 20030059829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/905381
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 125
[patent_figures_cnt] => 125
[patent_no_of_words] => 117829
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059829.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905381
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905381 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 12, 2001 | Issued |
Array
(
[id] => 6673829
[patent_doc_number] => 20030059432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Lipophilin complexes for use in cancer diagnosis and therapy'
[patent_app_type] => new
[patent_app_number] => 09/905673
[patent_app_country] => US
[patent_app_date] => 2001-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 22350
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059432.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905673
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905673 | Lipophilin complexes for use in cancer diagnosis and therapy | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6555506
[patent_doc_number] => 20020111470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/899651
[patent_app_country] => US
[patent_app_date] => 2001-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4153
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111470.pdf
[firstpage_image] =>[orig_patent_app_number] => 09899651
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/899651 | Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof | Jul 5, 2001 | Issued |
| 09/869685 | Predictive methods based on alpha-1-acid glycoprotein levels | Jun 28, 2001 | Abandoned |
Array
(
[id] => 490457
[patent_doc_number] => 07214770
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Screening Methods'
[patent_app_type] => utility
[patent_app_number] => 09/896791
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6344
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214770.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896791
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896791 | Screening Methods | Jun 28, 2001 | Issued |
Array
(
[id] => 5789580
[patent_doc_number] => 20020161212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells'
[patent_app_type] => new
[patent_app_number] => 09/887593
[patent_app_country] => US
[patent_app_date] => 2001-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22949
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20020161212.pdf
[firstpage_image] =>[orig_patent_app_number] => 09887593
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/887593 | BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells | Jun 20, 2001 | Abandoned |
Array
(
[id] => 773173
[patent_doc_number] => 07001735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Glucose transporter/sensor protein and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/886954
[patent_app_country] => US
[patent_app_date] => 2001-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16848
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001735.pdf
[firstpage_image] =>[orig_patent_app_number] => 09886954
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/886954 | Glucose transporter/sensor protein and uses thereof | Jun 20, 2001 | Issued |
Array
(
[id] => 623793
[patent_doc_number] => 07138501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Antibodies that immunospecifically bind BLyS'
[patent_app_type] => utility
[patent_app_number] => 09/880748
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 179723
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138501.pdf
[firstpage_image] =>[orig_patent_app_number] => 09880748
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/880748 | Antibodies that immunospecifically bind BLyS | Jun 14, 2001 | Issued |
Array
(
[id] => 6850995
[patent_doc_number] => 20030143198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Method for preparing a physiologically active il-18 polypeptide'
[patent_app_type] => new
[patent_app_number] => 10/311491
[patent_app_country] => US
[patent_app_date] => 2002-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 8015
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143198.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311491 | Method for preparing a physiologically active IL-18 polypeptide | Jun 10, 2001 | Issued |
Array
(
[id] => 5814683
[patent_doc_number] => 20020039735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Monoclonal antibodies to ING1 isoforms'
[patent_app_type] => new
[patent_app_number] => 09/874347
[patent_app_country] => US
[patent_app_date] => 2001-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5686
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20020039735.pdf
[firstpage_image] =>[orig_patent_app_number] => 09874347
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/874347 | Monoclonal antibodies to ING1 isoforms | Jun 3, 2001 | Abandoned |
Array
(
[id] => 6095313
[patent_doc_number] => 20020051813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Lipomatrix preparation'
[patent_app_type] => new
[patent_app_number] => 09/870691
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5412
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20020051813.pdf
[firstpage_image] =>[orig_patent_app_number] => 09870691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/870691 | Lipomatrix preparation | May 31, 2001 | Abandoned |
| 09/733956 | Tnfr-like protein with death domain | May 31, 2001 | Abandoned |
Array
(
[id] => 6082286
[patent_doc_number] => 20020082207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Compositions and methods for the therapy and diagnosis of pancreatic cancer'
[patent_app_type] => new
[patent_app_number] => 09/872153
[patent_app_country] => US
[patent_app_date] => 2001-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34798
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082207.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872153
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872153 | Compositions and methods for the therapy and diagnosis of pancreatic cancer | May 30, 2001 | Abandoned |
Array
(
[id] => 776730
[patent_doc_number] => 06998125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-14
[patent_title] => 'Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis'
[patent_app_type] => utility
[patent_app_number] => 09/853581
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5607
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/998/06998125.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853581
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853581 | Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis | May 13, 2001 | Issued |
Array
(
[id] => 6891892
[patent_doc_number] => 20010018054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis'
[patent_app_type] => new
[patent_app_number] => 09/853580
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5524
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018054.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853580
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853580 | Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis | May 13, 2001 | Abandoned |
